Variable | RA patients (n = 157) |
---|---|
Demographic characteristics | |
Age (years), mean ± SD | 55.3 ± 9.4 |
Female, n (%) | 149 (94.9) |
BMI (kg/m2) mean ± SD | 29.37 ± 5.68 |
Systolic blood pressure, mean ± SD | 123 ± 17 |
Traditional cardiovascular risk factors | |
Dyslipidemia, n (%) | 36 (22.9) |
Hypertension, n (%) | 54 (34.4) |
Obesity, n (%) | 60 (38.2) |
T2DM, n (%) | 25 (15.9) |
Active smokers, n (%) | 15 (9.6) |
Former smokers, n (%) | 19 (12.1) |
Antihypertensive treatment, n (%) | 48 (30.6) |
Lipid profile | |
Total cholesterol (mg/dl), mean ± SD | 177.6 ± 34.1 |
Triglycerides (mg/dl), median (p25–p75) | 128 (92.1–163.8) |
LDL-C (mg/dl), mean ± SD | 96 ± 29.1 |
HDL-C (mg/dl), median (p25–p75) | 51.8 (43.9–61.9) |
Disease characteristics | |
Disease duration (years), median (p25–p75) | 8.4 (3.7–16.2) |
DAS28-CRP, mean ± SD | 3.45 (± 1.37) |
Disease activity classification (DAS28-CRP) | |
Remission, n (%) | 50 (31.2) |
Low, n (%) | 20 (12.7) |
Moderate, n (%) | 65 (41.4) |
High, n (%) | 22 (14) |
HAQ, median (p25-p75) | 0.38 (0–1.06) |
Positive RF, n (%) | 132 (84.1) |
Positive anti-CCP, n (%) | 99 (63.1) |
CRP (mg/dl), median (p25–p75) | 0.81(0.5–1.25) |
ESR (mm/h), median (p25–p75) | 23 (15–37) |
Treatment | |
MTX, n (%) | 123 (78.3) |
Glucocorticoids, n (%) | 87 (55.4) |
bDMARD, n (%) | 15 (9.6) |